Hypervirulent Klebsiella pneumoniae (hvKP) is traditionally defined by hypermucoviscosity, but data based on genetic background are limited. Antimicrobial-resistant hvKP has been increasingly reported but has not yet been systematically studied. K. pneumoniae isolates from bloodstream infections, hospital-acquired pneumonia, and intra-abdominal infections were collected from 10 cities in China during February to July 2013. Clinical data were collected from medical records. All K. pneumoniae isolates were investigated by antimicrobial susceptibility testing, string test, extended-spectrum -lactamase (ESBL) gene detection, capsular serotypes, virulence gene profiles, and multilocus sequence typing. hvKP was defined by aerobactin detection. Of 230 K. pneumoniae isolates, 37.8% were hvKP. The prevalence of hvKP varied among different cities, with the highest rate in Wuhan (73.9%) and the lowest in Zhejiang (8.3%). Hypermucoviscosity and the presence of K1, K2, K20, and rmpA genes were strongly associated with hvKP (P < 0.001). A significantly higher incidence of liver abscess (P ؍ 0.026), sepsis (P ؍ 0.038), and invasive infections (P ؍ 0.043) was caused by hvKP. Cancer (odds ratio [OR], 2.285) and diabetes mellitus (OR, 2.256) appeared to be independent variables associated with hvKP infections by multivariate analysis. Importantly, 12.6% of hvKP isolates produced ESBLs, and most of them carried bla CTX-M genes. Patients with neutropenia (37.5% versus 5.6%; P ؍ 0.020), history of systemic steroid therapy (37.5% versus 5.6%; P ؍ 0.020), and combination therapy (62.5% versus 16.7%; P ؍ 0.009) were more likely to be infected with ESBL-producing hvKP. The prevalence of hvKP is high in China and has a varied geographic distribution. ESBLproducing hvKP is emerging, suggesting an urgent need to enhance clinical awareness, especially for immunocompromised patients receiving combination therapy.
Over the past few decades, increasing rates of hypervirulent Klebsiella pneumoniae (hvKP) infection have been reported worldwide (1-4). Such strains are notorious for their capacity to cause serious and metastatic infections in young and healthy individuals, such as pyogenic liver abscesses and endophthalmitis (5). Hypermucoviscosity is an important in vitro parameter for identification of hvKP (6, 7). However, several controversies have arisen regarding the association of hypermucoviscosity phenotype and virulence (8, 9). Hypermucoviscosity-negative strains are more prone to cause severe infections and have a higher mortality rate in diabetic mice than hypermucoviscous K. pneumoniae (8). Our previous study also demonstrated that one of the five hypermucoviscous K. pneumoniae isolates showed high virulence in both in vitro and in vivo assays (9). Therefore, it is apparent that hvKP cannot be defined by string test alone (10). Aerobactin accounts for increased siderophore production and is a major virulence determinant and new defining trait for hvKP based on genetic background (11). Some advances have been made recently...